Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by landsman8on Jan 04, 2003 7:21pm
455 Views
Post# 5729129

NRI price spikes

NRI price spikesWhen NRI ran up to $6.20 I noticed that Larry Roulston or Brian Lundin had recommended it, Roulston was where I first found mention in the summer of "01. Both have done so since. I would attribute a part of the spike to this esp. w/their stateside audiences. Shorting would be expected to come in here as momentum slows. Then the PDG announcement and reserve reports were not the excitement that people expected. Now Dines' call and Investor's Digest may be behind this latest rise. Offers good trading opportunities as well as a long term holding. For knowledgeable investors, taking some $ off the table on strength allows one to put it into smaller companies that haven't moved yet, swapping certainty for uncertainty and possibly more leverage. Sprucebruce's line of banter discouraged me from looking into IWA. Finally did and am impressed. Now that NRI has come to life again, where is the timberman now? It wasy impression that John Embry @ Royal Bank/Canada had done very well with NRI, don't see it in their portfolio now. Landsman.
Bullboard Posts